Healthcare provider profile · identity verified

Olga Sandel, PAC

Physician Assistant · BALTIMORE, MD · NPI 1619158896

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	778	112
Metoprolol Succinate	Metoprolol Succinate	742	97
Rosuvastatin Calcium	Rosuvastatin Calcium	534	76
Valsartan	Valsartan	497	69
Atorvastatin Calcium	Atorvastatin Calcium	403	54
Meclizine Hcl	Meclizine Hcl	402	60
Pantoprazole Sodium	Pantoprazole Sodium	343	50
Omeprazole	Omeprazole	339	42
Losartan Potassium	Losartan Potassium	337	42
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	332	52
Ammonium Lactate	Ammonium Lactate	325	51
Albuterol Sulfate Hfa	Albuterol Sulfate	320	50
Creon	Lipase/Protease/Amylase	301	47
Furosemide	Furosemide	298	41
Levothyroxine Sodium	Levothyroxine Sodium	265	31
Vascepa	Icosapent Ethyl	265	41
Eliquis	Apixaban	257	31
Gabapentin	Gabapentin	244	39
Fluticasone Propionate	Fluticasone Propionate	242	50
Metformin Hcl	Metformin Hcl	210	27
Nystatin	Nystatin	200	30
Metoprolol Tartrate	Metoprolol Tartrate	196	21
Tamsulosin Hcl	Tamsulosin Hcl	181	22
Nitroglycerin Patch	Nitroglycerin	175	25
Lidocaine-Prilocaine	Lidocaine/Prilocaine	174	37
Linzess	Linaclotide	171	29
Hydrochlorothiazide	Hydrochlorothiazide	155	27
Clopidogrel	Clopidogrel Bisulfate	151	20
Pravastatin Sodium	Pravastatin Sodium	150	22
Lactulose	Lactulose	145	23
Diclofenac Sodium	Diclofenac Sodium	143	29
Allopurinol	Allopurinol	127	14
Lisinopril	Lisinopril	126	16
Hydralazine Hcl	Hydralazine Hcl	121	24
Alendronate Sodium	Alendronate Sodium	109	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	106	23
Jardiance	Empagliflozin	106	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	105	11
Escitalopram Oxalate	Escitalopram Oxalate	98	21
Simvastatin	Simvastatin	98	11
Esomeprazole Magnesium	Esomeprazole Magnesium	91	17
Ezetimibe	Ezetimibe	81	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	81	suppressed
Spironolactone	Spironolactone	81	12
Carvedilol	Carvedilol	78	16
Icosapent Ethyl	Icosapent Ethyl	78	30
Colchicine	Colchicine	77	14
Zenpep	Lipase/Protease/Amylase	71	11
Amiodarone Hcl	Amiodarone Hcl	70	suppressed
Atenolol	Atenolol	60	suppressed
Nifedipine Er	Nifedipine	60	suppressed
Xarelto	Rivaroxaban	56	suppressed
Ketoconazole	Ketoconazole	55	12
Metformin Hcl Er	Metformin Hcl	55	11
Montelukast Sodium	Montelukast Sodium	53	suppressed
Dexlansoprazole Dr	Dexlansoprazole	49	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	48	suppressed
Dutasteride	Dutasteride	45	suppressed
Myrbetriq	Mirabegron	45	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	12
Lidocaine	Lidocaine	41	suppressed
Benazepril Hcl	Benazepril Hcl	40	suppressed
Ranolazine Er	Ranolazine	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	33
Terazosin Hcl	Terazosin Hcl	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Irbesartan	Irbesartan	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Trazodone Hcl	Trazodone Hcl	34	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Famotidine	Famotidine	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Sucralfate	Sucralfate	29	suppressed
Procto-Med Hc	Hydrocortisone	28	suppressed
Cefdinir	Cefdinir	27	21
Ibandronate Sodium	Ibandronate Sodium	27	suppressed
Mupirocin	Mupirocin	27	20
Telmisartan	Telmisartan	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Ozempic	Semaglutide	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Finasteride	Finasteride	20	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	20	suppressed
Azithromycin	Azithromycin	19	17
Methimazole	Methimazole	19	suppressed
Methylprednisolone	Methylprednisolone	18	17
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Glimepiride	Glimepiride	15	suppressed
Kerendia	Finerenone	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Fluocinolone Acetonide	Fluocinolone Acetonide	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Prednisone	Prednisone	14	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Selenium Sulfide	Selenium Sulfide	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Invokana	Canagliflozin	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Mitigare	Colchicine	11	suppressed
Sertraline Hcl	Sertraline Hcl	11	suppressed
Trandolapril	Trandolapril	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed
Ubrelvy	Ubrogepant	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error